Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa.

類似資料

• Current Use of Nucleoside Analogues in the Treatment of HIV Infection
  著者:: Julio SG Montaner, 等
  出版事項: (1994-01-01)
• Management of Chronic Hepatitis B with Nucleoside or Nucleotide Analogues: A Review of Current Guidelines
  出版事項: (2010-03-01)
• Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA).
  著者:: Dart Trial Team
  出版事項: (2008)
• Production of Value-Added Arabinofuranosyl Nucleotide Analogues from Nucleoside by an In Vitro Enzymatic Synthetic Biosystem
  著者:: Yuxue Liu, 等
  出版事項: (2024-11-01)
• Chemical synthesis of nucleoside analogues /
  著者:: Merino, Pedro, 等
  出版事項: (2013)